Stock DNA
Medical Distributors
USD 2,772 Million (Small Cap)
19.00
NA
10,993.26%
0.65
14.45%
2.80
Revenue and Profits:
Net Sales:
1,572 Million
(Quarterly Results - Jan 2025)
Net Profit:
31 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.46%
0%
1.46%
6 Months
50.05%
0%
50.05%
1 Year
22.24%
0%
22.24%
2 Years
17.96%
0%
17.96%
3 Years
-10.51%
0%
-10.51%
4 Years
-3.03%
0%
-3.03%
5 Years
109.15%
0%
109.15%
Patterson Cos., Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
2.91%
EBIT Growth (5y)
1.97%
EBIT to Interest (avg)
8.28
Debt to EBITDA (avg)
1.81
Net Debt to Equity (avg)
0.65
Sales to Capital Employed (avg)
3.76
Tax Ratio
24.50%
Dividend Payout Ratio
52.40%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
15.30%
ROE (avg)
19.13%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
2.80
EV to EBIT
15.24
EV to EBITDA
10.81
EV to Capital Employed
2.09
EV to Sales
0.52
PEG Ratio
NA
Dividend Yield
10993.26%
ROCE (Latest)
13.73%
ROE (Latest)
14.45%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Jan 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 91 Schemes (53.17%)
Foreign Institutions
Held by 144 Foreign Institutions (10.27%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jan'25 - QoQ
Jan'25
Oct'24
Change(%)
Net Sales
1,572.40
1,674.40
-6.09%
Operating Profit (PBDIT) excl Other Income
71.30
74.60
-4.42%
Interest
10.40
11.50
-9.57%
Exceptional Items
2.30
-10.90
121.10%
Consolidate Net Profit
31.20
26.70
16.85%
Operating Profit Margin (Excl OI)
30.60%
30.90%
-0.03%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jan 2025 is -6.09% vs 8.61% in Oct 2024
Consolidated Net Profit
QoQ Growth in quarter ended Jan 2025 is 16.85% vs 96.32% in Oct 2024
Annual Results Snapshot (Consolidated) - Apr'24
Apr'24
Apr'23
Change(%)
Net Sales
6,568.30
6,471.50
1.50%
Operating Profit (PBDIT) excl Other Income
354.90
367.50
-3.43%
Interest
43.50
32.30
34.67%
Exceptional Items
12.40
10.00
24.00%
Consolidate Net Profit
185.50
206.60
-10.21%
Operating Profit Margin (Excl OI)
40.60%
43.80%
-0.32%
USD in Million.
Net Sales
YoY Growth in year ended Apr 2024 is 1.50% vs -0.43% in Apr 2023
Consolidated Net Profit
YoY Growth in year ended Apr 2024 is -10.21% vs 2.43% in Apr 2023
About Patterson Cos., Inc. 
Patterson Cos., Inc.
Medical Distributors
Patterson Companies, Inc. is a value-added distributor focused on providing a customer experience to professionals in the dental and animal health markets. The Company operates through three segments: dental, animal health and corporate. Dental and Animal health are strategic business units that offer similar products and services to different customer bases. Dental provides a virtually complete range of consumable dental products, equipment and software and turnkey digital solutions. In addition it provides value-added services to dentists, dental laboratories, institutions and other healthcare professionals throughout North America. Animal health is a leading, full-line distributor of animal health products, services and technologies. Corporate segment is comprised of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources and facilities.
Company Coordinates 
Company Details
1031 Mendota Heights Rd , SAINT PAUL MN : 55120-1401
Registrar Details






